Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.42 USD | +2.05% |
|
+11.42% | -19.27% |
07-09 | Arcus Biosciences Says Taiho Has Exercised Option for Exclusive License to Quemliclustat in Japan | MT |
07-05 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.27% | 1.4B | |
+22.15% | 46.56B | |
+45.94% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Arcus Biosciences Says Taiho Has Exercised Option for Exclusive License to Quemliclustat in Japan